Cibc World Markets Corp acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 18,641 shares of the company's stock, valued at approximately $251,000.
Other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp raised its holdings in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock valued at $108,867,000 after acquiring an additional 291,335 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Oscar Health by 11.7% during the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company's stock worth $92,062,000 after purchasing an additional 455,205 shares during the last quarter. Hennessy Advisors Inc. raised its stake in Oscar Health by 550.3% during the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after buying an additional 3,544,300 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Oscar Health by 68.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company's stock worth $48,977,000 after buying an additional 938,742 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Oscar Health by 3.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,654,862 shares of the company's stock worth $22,241,000 after acquiring an additional 54,696 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.
Oscar Health Stock Performance
Shares of OSCR traded down $0.20 during trading hours on Friday, reaching $13.29. 2,753,355 shares of the company traded hands, compared to its average volume of 3,758,190. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock's fifty day moving average is $14.90 and its 200 day moving average is $16.09. Oscar Health, Inc. has a 1-year low of $12.43 and a 1-year high of $23.79. The stock has a market cap of $3.33 billion, a P/E ratio of -663.92 and a beta of 1.75.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Equities research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
OSCR has been the subject of a number of research reports. Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Jefferies Financial Group initiated coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Oscar Health currently has an average rating of "Hold" and an average price target of $20.21.
Get Our Latest Analysis on OSCR
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.